Literature DB >> 6301994

Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.

S A Huber, L P Job.   

Abstract

Two strains of coxsackie B-3 virus, indistinguishable by neutralization with acute mouse antiserum to coxsackie B-3 group virus, differ markedly in pathogenicity. One strain induces extensive mononuclear cell infiltration and necrosis in the heart, and 92% of the infected animals die by day 10 after infection. Inflammation, cardiac damage, and mortality are reduced in mice infected with the nonmyocarditic virus. Peak virus replication occurs on day 3 with both viruses. Virus concentrations decrease to undetectable levels after day 12 of infection. Cytolytic T cells could be isolated from the spleens of animals inoculated with either virus. The spleen cells preferentially lysed target cells infected with the immunizing virus strain. These results suggest that the myocarditic and nonmyocarditic viruses induce only minimally noncross-reacting virus-specific antigens on the target cell surface.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301994      PMCID: PMC348113          DOI: 10.1128/iai.39.3.1419-1427.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Myocarditis in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

2.  Coxsackie virus infections of the newborn.

Authors:  J H GEAR
Journal:  Prog Med Virol       Date:  1958

3.  Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold.

Authors:  W D BORING; D L WALKER; G M ZU RHEIN
Journal:  Proc Soc Exp Biol Med       Date:  1956-11

4.  Limited persistence of viral antigen in coxsackievirus B3 induced heart disease in mice.

Authors:  T G Roesing; B J Landau; R L Crowell
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

5.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

6.  Replication of poliovirus RNA studied by gel filtration and electrophoresis.

Authors:  B Oberg; L Philipson
Journal:  Eur J Biochem       Date:  1969-12

Review 7.  Adult heart disease due to the Coxsackie virus B infection.

Authors:  G S Sainani; E Krompotic; S J Slodki
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

8.  Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.

Authors:  C J Gauntt; M D Trousdale; D R LaBadie; R E Paque; T Nealon
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

10.  Lesions caused in suckling mice by certain viruses isolated from cases of so called non-paralytic poliomyelitis and of pleurodynia.

Authors:  A M PAPPENHEIMER; J B DANIELS; F S CHEEVER; T H WELLER
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

View more
  21 in total

Review 1.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.

Authors:  M Estrin; C Smith; S Huber
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 5.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Derivation and characterization of an efficiently myocarditic reovirus variant.

Authors:  B Sherry; F J Schoen; E Wenske; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.

Authors:  S Sriram; D J Topham; S K Huang; M Rodriguez
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.

Authors:  N Van Houten; P E Bouchard; A Moraska; S A Huber
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 10.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.